The Joint Corp. Stock Price and Value Analysis

Should you buy The Joint Corp. stock? (NasdaqCM:JYNT). Let's see how it does in our automated value investing analysis system.

JYNT Free Cash Flow Trend

Free Cash Flow trendline for JYNT
Free Cash Flow trendline for The Joint Corp.

Hmm, we can't give any reliable projection for The Joint Corp.'s growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the JYNT Numbers

JYNT Price
(The Joint Corp. stock price per share)
[?] PE Ratio versus Sector 583% higher than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Medical Care stocks
[?] Free Cash Flow Jitter 83%

Is The Joint Corp. Stock on Sale?

Based on our analysis, we believe that you should not buy The Joint Corp. right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy JYNT Stock?

Does The Joint Corp. have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.